

AstraZeneca & Daiichi Sankyo team up with Summit Therapeutics to test Datroway + ivonescimab combo in triple-negative breast cancer.
You can purchase shares of Summit Therapeutics (NASDAQ:SMMT) through any online brokerage.
Other companies in Summit Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Summit Therapeutics has a consensus price target of $31.86.
The stock price for Summit Therapeutics (NASDAQ: SMMT) is $14.1699 last updated November 13, 2026 at 7:59 PM EST.
There are no upcoming dividends for Summit Therapeutics.
Summit Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Summit Therapeutics.
Summit Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is...